Mirae Asset Global Investments’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-23,195
Closed -$74K 1652
2024
Q1
$74K Buy
+23,195
New +$71.6K ﹤0.01% 2408
2023
Q2
Sell
-23,195
Closed -$78.4K 2611
2023
Q1
$78.4K Hold
23,195
﹤0.01% 2479
2022
Q4
$83K Hold
23,195
﹤0.01% 2480
2022
Q3
$93K Buy
23,195
+7,140
+44% +$36.7K ﹤0.01% 2516
2022
Q2
$72K Buy
+16,055
New +$116K ﹤0.01% 2351

Other funds holding SRTA

Mirae Asset Global Investments's SRTA Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Strata Critical Medical Inc (SRTA) in Q2 2024, closing a stake of 23,195 shares — an estimated $74K sold.

Mirae Asset Global Investments first reported a position in SRTA in Q2 2022 and held it in 5 quarters. The position peaked at $93K in Q3 2022. 117 funds tracked by Wall St. Rank hold SRTA as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining Strata Critical Medical Inc position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 23,195 Strata Critical Medical Inc shares in Q2 2024, an estimated $74K.
  • Mirae Asset Global Investments first reported a position in Strata Critical Medical Inc in Q2 2022 and held it in 5 quarters.
  • Mirae Asset Global Investments's Strata Critical Medical Inc position peaked at $93K in Q3 2022.
  • 117 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.